Friday, September 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Buy Rating and Price Target for Crane NXT

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
EEFT stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, DA Davidson analyst Matt Summerville reiterated a Buy rating on Crane NXT (NYSE:CXT) with a price target of $80. This reaffirmation follows a previous price target increase from $75 to $80 on January 18th. Analysts, including Oppenheimer, have expressed optimism about Crane NXT’s performance in security and currency authentication, further supporting the positive outlook for the company.

CXT Stock Shows Strong Performance on March 12, 2024: Positive Signs of Growth and Stability

On March 12, 2024, CXT stock showed strong performance as it continued to trade near the top of its 52-week range and above its 200-day simple moving average. The price of CXT shares increased by $0.01 since the market last closed, representing a 0.02% rise. As of the last close, CXT was trading at $59.60. Overall, the performance of CXT stock on March 12, 2024, was positive and showed signs of strength and stability. Investors who have been holding onto CXT shares may have seen their investments grow, and this could be a good indication of future potential for the stock.

CXT Stock Performance Analysis: Revenue and Net Income Decline in 2024

On March 12, 2024, CXT stock experienced a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $1.39 billion, which decreased by 58.78% compared to the previous year. However, the total revenue remained flat since the last quarter at $356.90 million.

Similarly, CXT’s net income for the past year was $188.30 million, showing a decrease of 53.05% from the previous year. The net income also decreased by 4.62% since the last quarter, standing at $49.50 million. Earnings per share (EPS) for the past year was $3.27, which decreased by 53.3% compared to the previous year. The EPS remained flat since the last quarter at $0.86.

Overall, CXT stock’s performance on March 12, 2024, reflected a decline in total revenue, net income, and earnings per share compared to the previous year. However, the company managed to hold its revenue and EPS flat since the last quarter. Investors and analysts may closely monitor CXT’s financial performance in the coming quarters to assess the company’s growth prospects and profitability.

Tags: CXT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

EFTR Trading Halt Lifted After Pending News Release

Biotechnology Stock Market Today (1)

Revolutionizing CAR T Therapy A Groundbreaking Global Gene Editing Licensing Agreement

DrugRetailers Stock Exchange

Analysts Bullish on Academy Sports with Strong Buy Consensus

Recommended

DVY stock news

Analyzing the Rise and Fall of Short Interest in Procaps Group S.A.: Insights for Investors

2 years ago
Apple Stock

Apple Stock: Soars on $100B US Investment and Samsung Chip Deal

4 weeks ago
Miniso Holding Ltd Stock

Miniso Shares Surge on Exceptional Quarterly Performance

6 days ago
Renewable energy

Imperial Oil AMEX IMO Stock Analysis Impressive Performance and Growth Potential

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet AMD AMZN Apple BA Broadcom C Coinbase COST CRWD DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSFT NIO Nvidia Opendoor Oracle Palantir Pepsi PLTR Realty Income Red Cat Robinhood Rocket Lab USA Salesforce SMCI Strategy Tesla Tilray TSLA Unitedhealth Wolfspeed
No Result
View All Result

Highlights

NuCana Approaches Critical Clinical and Financial Juncture

Realty Income’s Dividend Legacy Faces Market Pressure

Walgreens Concludes 125-Year Public Market Chapter with $10 Billion Take-Private Deal

Kraft Heinz Shares Plunge on Breakup Strategy Concerns

Tesla’s AI Pivot: Strategic Masterstroke or High-Stakes Gamble?

Alphabet Shares Surge as Court Decision Preserves Tech Giant’s Core Business

Trending

Denali Therapeutics Stock
Analysis

Denali Therapeutics: A Study in Institutional Confidence and Insider Divestment

by Andreas Sommer
September 5, 2025
0

The investment narrative surrounding Denali Therapeutics presents a fascinating paradox. While its pipeline of therapies for neurodegenerative...

Uranium Energy Stock

A Quiet Leader in America’s Nuclear Energy Revival

September 5, 2025
Exxon Mobil Stock

Exxon Mobil’s Strategic Pivot: Divesting in Europe While Expanding African Operations

September 5, 2025
NuCana Stock

NuCana Approaches Critical Clinical and Financial Juncture

September 5, 2025
Realty Income Stock

Realty Income’s Dividend Legacy Faces Market Pressure

September 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Denali Therapeutics: A Study in Institutional Confidence and Insider Divestment September 5, 2025
  • A Quiet Leader in America’s Nuclear Energy Revival September 5, 2025
  • Exxon Mobil’s Strategic Pivot: Divesting in Europe While Expanding African Operations September 5, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com